3,3'-Diindolylmethane
Natural health product licensed in Canada
- Licence holder
- Sabinsa Canada Inc.
- NPN or DIN-HM
- 80062592
- Status
- Active licence
- Licence date
- 9 July 2015
- Revision date
- 29 July 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 100 milligramme | Not calculated |
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 2 Pour cent | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
ANTIOXIDANT. SUPPORTS HEALTHY ESTROGEN METABOLISM/ BALANCE. HELPS REDUCE SEVERITY AND DURATION OF SYMPTOMS ASSOCIATED WITH RECURRENT BREAST PAIN (CYCLICAL MASTALGIA).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
if you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
If you are taking any medication or natural health products , consult a health care practitioner prior to use. If you are attempting to conceive, consult a health care practitioner prior to use. If you have a liver disorder or symptoms of low estrogen (such as joint pain, mood changes, change in libido, hot flashes, night sweats, vaginal dryness or irregular menstruations), consult a healthcare practitioner prior to use. If you develop liver-related symptoms (eg abdominal pain, jaundice) or symptoms of low estrogen, discontinue use and consult a health care practitioner. to exclude the diagnosis of a serious cause of hormonal imbalance, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80062592
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.